Pancreas-Kidney Transplantation: Analysis of 150 patients from one Centre in Portugal
Introduction: Simultaneous pancreas-kidney transplantation (SPKT) outcomes are conditioned in the short-term mostly by post-operative complications. In the long-term, cardiovascular (CV) disease and immunological loss are the main limitations to transplant survival. Aims: To analyse retrospectively the results from 150 SPKT performed at our centre. Patients and Methods: The 81 females and 69 males had a mean age of 35 ±6 years; they were diabetic for 24 ±6 years and had been on dialysis for 30±21months (except 5 preemptive). Anti-lymphocyte globulin, tacrolimus, mycophenolate and steroids were used as immunosuppressive therapy. Deceased-donor mean age was 28 ±11 years. In 28.7% the transplant was performed with 6 HLA-mismatches. Results: Acute rejections incidence was 16%. Ten SPKT patients died; infection was the leading cause of death (five cases), followed by Cardiovascular/cerebrovascular disease (three cases). In 21 patients the pancreas failed, mainly due to thrombosis or bleeding (11 cases), and infection (five cases); in two it was due to late acute rejection. In four patients only the kidney failed, due to chronic rejection. Five patients lost both grafts, from late acute rejection in four and thrombosis in one. We analyzed the 110 SPKT patients (73.3%) with both grafts functioning. Their mean serum creatinine was 1.2 ±0.4mg/dl; creatinineclearance was 76±24 ml/min; fasting glycaemia was 81 ±10mg/dl; and HbA1c was 5.3±0.4%. Hypertension has been treated in 47.2% of patients, in the majority (28.2%) with only one drug. Hyperlipidaemia was observed in 19.1% and excessive weight (>25kg/m2) in 17.3%. Conclusions: From our cohort of SPKT, 93.3% of patients are alive, 73.3% have both grafts functioning. Rejection was the main cause of late pancreas loss. Early mortality was due to infection (3.3%). CV/cerebrovascular disease was the main cause of late mortality (2%). The prevalence of hyperlipidaemia and overweight was inferior to 20%. Hypertension was the most frequently found CV risk factor
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Portuguesa de Nefrologia
2013
|
Online Access: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692013000300006 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0872-01692013000300006 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0872-016920130003000062014-01-28Pancreas-Kidney Transplantation: Analysis of 150 patients from one Centre in PortugalMartins,La SaleteFonseca,IsabelAguiar,PedroRocha,AnaCosta,RuiSantos,ClaraMalheiro,JorgePedroso,SofiaAlmeida,ManuelaDias,LeonidioHenriques,Antonio CCabrita,AntonioDavide,Jose graft loss long-term results pancreas-kidney transplantation patient death Introduction: Simultaneous pancreas-kidney transplantation (SPKT) outcomes are conditioned in the short-term mostly by post-operative complications. In the long-term, cardiovascular (CV) disease and immunological loss are the main limitations to transplant survival. Aims: To analyse retrospectively the results from 150 SPKT performed at our centre. Patients and Methods: The 81 females and 69 males had a mean age of 35 ±6 years; they were diabetic for 24 ±6 years and had been on dialysis for 30±21months (except 5 preemptive). Anti-lymphocyte globulin, tacrolimus, mycophenolate and steroids were used as immunosuppressive therapy. Deceased-donor mean age was 28 ±11 years. In 28.7% the transplant was performed with 6 HLA-mismatches. Results: Acute rejections incidence was 16%. Ten SPKT patients died; infection was the leading cause of death (five cases), followed by Cardiovascular/cerebrovascular disease (three cases). In 21 patients the pancreas failed, mainly due to thrombosis or bleeding (11 cases), and infection (five cases); in two it was due to late acute rejection. In four patients only the kidney failed, due to chronic rejection. Five patients lost both grafts, from late acute rejection in four and thrombosis in one. We analyzed the 110 SPKT patients (73.3%) with both grafts functioning. Their mean serum creatinine was 1.2 ±0.4mg/dl; creatinineclearance was 76±24 ml/min; fasting glycaemia was 81 ±10mg/dl; and HbA1c was 5.3±0.4%. Hypertension has been treated in 47.2% of patients, in the majority (28.2%) with only one drug. Hyperlipidaemia was observed in 19.1% and excessive weight (>25kg/m2) in 17.3%. Conclusions: From our cohort of SPKT, 93.3% of patients are alive, 73.3% have both grafts functioning. Rejection was the main cause of late pancreas loss. Early mortality was due to infection (3.3%). CV/cerebrovascular disease was the main cause of late mortality (2%). The prevalence of hyperlipidaemia and overweight was inferior to 20%. Hypertension was the most frequently found CV risk factorinfo:eu-repo/semantics/openAccessSociedade Portuguesa de NefrologiaPortuguese Journal of Nephrology & Hypertension v.27 n.3 20132013-09-01info:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692013000300006en |
institution |
SCIELO |
collection |
OJS |
country |
Portugal |
countrycode |
PT |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-pt |
tag |
revista |
region |
Europa del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Martins,La Salete Fonseca,Isabel Aguiar,Pedro Rocha,Ana Costa,Rui Santos,Clara Malheiro,Jorge Pedroso,Sofia Almeida,Manuela Dias,Leonidio Henriques,Antonio C Cabrita,Antonio Davide,Jose |
spellingShingle |
Martins,La Salete Fonseca,Isabel Aguiar,Pedro Rocha,Ana Costa,Rui Santos,Clara Malheiro,Jorge Pedroso,Sofia Almeida,Manuela Dias,Leonidio Henriques,Antonio C Cabrita,Antonio Davide,Jose Pancreas-Kidney Transplantation: Analysis of 150 patients from one Centre in Portugal |
author_facet |
Martins,La Salete Fonseca,Isabel Aguiar,Pedro Rocha,Ana Costa,Rui Santos,Clara Malheiro,Jorge Pedroso,Sofia Almeida,Manuela Dias,Leonidio Henriques,Antonio C Cabrita,Antonio Davide,Jose |
author_sort |
Martins,La Salete |
title |
Pancreas-Kidney Transplantation: Analysis of 150 patients from one Centre in Portugal |
title_short |
Pancreas-Kidney Transplantation: Analysis of 150 patients from one Centre in Portugal |
title_full |
Pancreas-Kidney Transplantation: Analysis of 150 patients from one Centre in Portugal |
title_fullStr |
Pancreas-Kidney Transplantation: Analysis of 150 patients from one Centre in Portugal |
title_full_unstemmed |
Pancreas-Kidney Transplantation: Analysis of 150 patients from one Centre in Portugal |
title_sort |
pancreas-kidney transplantation: analysis of 150 patients from one centre in portugal |
description |
Introduction: Simultaneous pancreas-kidney transplantation (SPKT) outcomes are conditioned in the short-term mostly by post-operative complications. In the long-term, cardiovascular (CV) disease and immunological loss are the main limitations to transplant survival. Aims: To analyse retrospectively the results from 150 SPKT performed at our centre. Patients and Methods: The 81 females and 69 males had a mean age of 35 ±6 years; they were diabetic for 24 ±6 years and had been on dialysis for 30±21months (except 5 preemptive). Anti-lymphocyte globulin, tacrolimus, mycophenolate and steroids were used as immunosuppressive therapy. Deceased-donor mean age was 28 ±11 years. In 28.7% the transplant was performed with 6 HLA-mismatches. Results: Acute rejections incidence was 16%. Ten SPKT patients died; infection was the leading cause of death (five cases), followed by Cardiovascular/cerebrovascular disease (three cases). In 21 patients the pancreas failed, mainly due to thrombosis or bleeding (11 cases), and infection (five cases); in two it was due to late acute rejection. In four patients only the kidney failed, due to chronic rejection. Five patients lost both grafts, from late acute rejection in four and thrombosis in one. We analyzed the 110 SPKT patients (73.3%) with both grafts functioning. Their mean serum creatinine was 1.2 ±0.4mg/dl; creatinineclearance was 76±24 ml/min; fasting glycaemia was 81 ±10mg/dl; and HbA1c was 5.3±0.4%. Hypertension has been treated in 47.2% of patients, in the majority (28.2%) with only one drug. Hyperlipidaemia was observed in 19.1% and excessive weight (>25kg/m2) in 17.3%. Conclusions: From our cohort of SPKT, 93.3% of patients are alive, 73.3% have both grafts functioning. Rejection was the main cause of late pancreas loss. Early mortality was due to infection (3.3%). CV/cerebrovascular disease was the main cause of late mortality (2%). The prevalence of hyperlipidaemia and overweight was inferior to 20%. Hypertension was the most frequently found CV risk factor |
publisher |
Sociedade Portuguesa de Nefrologia |
publishDate |
2013 |
url |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692013000300006 |
work_keys_str_mv |
AT martinslasalete pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT fonsecaisabel pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT aguiarpedro pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT rochaana pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT costarui pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT santosclara pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT malheirojorge pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT pedrososofia pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT almeidamanuela pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT diasleonidio pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT henriquesantonioc pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT cabritaantonio pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal AT davidejose pancreaskidneytransplantationanalysisof150patientsfromonecentreinportugal |
_version_ |
1756001664440991744 |